Procter & Gamble’s fiscal first-quarter 2027 earnings release on October 22 anchors trader focus, with Wall Street consensus pointing to roughly 2% organic sales growth amid stabilizing U.S. consumption trends and mixed international results. The company’s full-year 1-3% guidance incorporates a 30-50 basis point headwind from product discontinuations plus roughly $1 billion in after-tax commodity, energy, and transportation cost pressures tied to geopolitical factors. Recent channel data show U.S. shopper purchases accelerating to 4.4% in the latest tracked period, supporting volume recovery, while pricing and mix contributions remain modest. The tightly bunched Polymarket probabilities—led by the 2.5-3.5% outcome at 27.5%—reflect uncertainty over whether Q1 volumes and category share gains can offset ongoing margin compression and deliver toward the upper end of the annual range.